WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Website Revenue Sunday, May 3, 2026 
Add Press Release News | News Feeds Feeds | Email This News Email


Parenteral Drug Association and Euromed Communications release Industrial Pharmaceutical Microbiology Under New Collaboration
Tuesday, October 3, 2023

The two publishers inked a new co-publishing agreement with the goal of publishing six technical books annually.

BETHESDA, Md., Sept. 25, 2023 /PRNewswire-PRWeb/ -- Parenteral Drug Association, Inc. (PDA) and based Euromed Communications today announced the publication of Industrial Pharmaceutical Microbiology: Standards & Controls (Sixth Edition), edited by Tim Sandle of Bio Products Laboratory, UK. This 700-page volume includes 25 chapters from 20 authors. Electronic copies are sold by both PDA and Euromed Communications and hardcopies exclusively by the latter company.

Under the co-publishing agreement, the publishers will work together to publish six technical books annually. These books will be relevant to the PDA community and the pharmaceutical industry at large.

To learn more about this title and/or to purchase it, click here to the PDA Bookstore or the Euromed Communications store.

"PDA looks forward to a productive partnership with Euromed Communications as we continue to serve our members, many of whom who are both authors as well as readers of technical books about pharmaceutical manufacturing, control and regulations," said Glenn Wright, PDA President & CEO. "Books by independent authors and editors represent a incredibly valuable offering in PDA's extensive technical library which also includes technical reports, standards, points-to-consider, and periodicals."

"Euromed Communications are delighted to join together with the PDA to co- produce technical and regulatory books and manuals for the cleanroom and associated pharma sectors" said Director Peter Hall. "In our new association with the PDA we can work together with the leading writers and experts from the US, Europe and the rest of the world to produce relevant and up to date publications for the wide readership of both the PDA and EC."

Under the co-publishing agreement, the publishers will work together to publish six technical books annually. These books will be relevant to the PDA community and the pharmaceutical industry at large.

Euromed Communications is an independent publishing company established in 1993 and has a core of professional writers and editors, supplemented by a team of international medical and scientific experts. It produces books and journals for the hospital, cleanroom, regulatory, and other pharmaceutical sectors. Over the years EC has built up close associations with various international pharmaceutical organisations such as the Royal Pharmaceutical Society (RPS), the Association of British Pharmaceutical Industries (ABPI), and the Federation of Industrial Pharmacists (FIP). They have also worked with the FDA, MHRA and the EMA. EC books and journals have been edited by some of the key medical and pharmaceutical opinion leaders. https://euromedcommunications.com/

Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation, so members can better serve patients. Go to http://www.pda.org/footer/about-pda to learn more.

Media Contact

Walter Morris, www.pda.org, 1 3016565900, morris@pda.org, www.pda.org

View original content to download multimedia:https://www.prweb.com/releases/parenteral-drug-association-and-euromed-communications-release-industrial-pharmaceutical-microbiology-under-new-collaboration-301936596.html

SOURCE Parenteral Drug Association



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav The New Identity Theft Crisis: AI Scams, Child Victims, and Credit Damage Are All Spiking | Jan 22, 2026
Nav AllSci Launches Hypothesis Publishing: A Seamless Way to Share, Connect, and Advance Scientific Ideas | Jan 22, 2026
Nav Canadian Fintech Tuhk Inc., Founded by Ethoca and NuData Security Veterans, Raises US$6 Million Seed Round Led by FINTOP, with Lloyds Banking Group and Capital One Ventures | Jan 22, 2026
Nav Darwin CX Caps a Banner Year with AI Launch, Sold-Out Events, and Industry Book Launch | Jan 22, 2026
Nav Fintech Startup BON Credit Secures $3.5 Million In Funding | Jan 22, 2026
Nav Nudge Security Unveils Industry's Most Comprehensive AI Security Governance Platform | Jan 22, 2026
Nav PayDo Launches Unified Payment Infrastructure Suite for Digital Businesses | Jan 22, 2026
Nav IoTeX Publishes MiCA-Compliant Whitepaper for IOTX, Enabling EU-Wide Alignment Under the New Regulatory Framework | Jan 22, 2026
Nav Gametime Launches "12 Days of Gametime" Holiday Giveaway in Partnership with Barstool Sports | Jan 22, 2026
Nav TSX Venture Exchange Market Data Now Available Across Over 40 Blockchains via Chainlink | Jan 22, 2026
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News